Stellanova Therapeutics rakes in $15.5m Series A

Stellanova Therapeutics Inc, a biotechnology company advancing cancer therapies targeting the tumor microenvironment, has secured $15.5 million in Series A financing.

Stellanova Therapeutics Inc, a biotechnology company advancing cancer therapies targeting the tumor microenvironment, has secured $15.5 million in Series A financing. Sporos Bioventures LLC led the round.

Source: Press Release